WEF recognizes a Bristol Myers Squibb cancer drug plant for innovation

In short: The World Economic Forum recognized a Bristol Myers Squibb plant that makes cancer medicines for innovation, according to a New York Times report.

What happened

Bristol Myers Squibb, a large drug company, has been recognized by the World Economic Forum (WEF) for innovation at one of its manufacturing plants, according to The New York Times.

The report says the plant makes cancer drugs. It also says it was the only manufacturer in the United States to get this type of innovation recognition from the WEF this year.

The WEF is an international group that brings together business and government leaders and it also runs programs that highlight certain companies and projects. Think of it like a well known conference organizer that also publishes lists of organizations it considers leaders in specific areas.

Why it matters

How medicines are made can affect supply, quality, and cost. When a major outside group highlights a drug plant for innovation, it can signal that the company is changing how it runs the factory, for example by using more automation or better ways to check quality. For patients, the practical question is whether these changes help medicines get made more reliably and with fewer disruptions.

Source: NYTimes